ATE393163T1 - Aib1, ein steroidrezeptor co-aktivator - Google Patents

Aib1, ein steroidrezeptor co-aktivator

Info

Publication number
ATE393163T1
ATE393163T1 AT98931358T AT98931358T ATE393163T1 AT E393163 T1 ATE393163 T1 AT E393163T1 AT 98931358 T AT98931358 T AT 98931358T AT 98931358 T AT98931358 T AT 98931358T AT E393163 T1 ATE393163 T1 AT E393163T1
Authority
AT
Austria
Prior art keywords
activator
aib1
steroid receptor
steroid
steroid hormone
Prior art date
Application number
AT98931358T
Other languages
English (en)
Inventor
Paul Meltzer
Jeffrey Trent
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE393163T1 publication Critical patent/ATE393163T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98931358T 1997-06-17 1998-06-17 Aib1, ein steroidrezeptor co-aktivator ATE393163T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4972897P 1997-06-17 1997-06-17

Publications (1)

Publication Number Publication Date
ATE393163T1 true ATE393163T1 (de) 2008-05-15

Family

ID=21961378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98931358T ATE393163T1 (de) 1997-06-17 1998-06-17 Aib1, ein steroidrezeptor co-aktivator

Country Status (8)

Country Link
US (3) US6562589B1 (de)
EP (1) EP0988317B1 (de)
JP (1) JP2002510208A (de)
AT (1) ATE393163T1 (de)
AU (1) AU732149B2 (de)
CA (1) CA2295332C (de)
DE (1) DE69839395D1 (de)
WO (1) WO1998057982A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032621A2 (en) * 1997-12-22 1999-07-01 American Home Products Corporation Nucleic acid sequences encoding nuclear receptor coactivator proteins and uses thereof
US7132258B1 (en) 1998-02-04 2006-11-07 University Of Massachusetts Nucleic acid encoding vitamin D receptor related polypeptide
US6156571A (en) * 1999-11-15 2000-12-05 Isis Pharmaceuticals Inc. Antisense inhibition of SRC-3 expression
IT1318608B1 (it) * 2000-07-04 2003-08-27 Univ Degli Studi Milano Topo transgenico per lo screening e per studi di farmacodinamica efarmacocinetica di ligandi attivi sul recettore degli estrogeni e sui
US20040259085A1 (en) * 2000-07-27 2004-12-23 Chawnshang Chang Methods and compositions for predicting prostate cancer
AU2002346049A1 (en) * 2001-07-05 2003-01-21 Georgetown University Medical Center Coactivators in the diagnosis and treatment of breast cancer
AU2003239158A1 (en) * 2002-04-17 2003-11-03 Baylor College Of Medicine Aib1 as a prognostic marker and predictor of resistance to encocrine therapy
IL149404A0 (en) * 2002-04-29 2002-11-10 Yissum Res Dev Co METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
EP1950293A4 (de) 2005-10-24 2009-09-09 Taiho Pharmaceutical Co Ltd Verfahren zur vorhersage der wirksamkeit eines rar-agonisten
EP2589961A3 (de) * 2006-09-06 2013-08-07 The Regents of the University of California Molekulare Diagnose und Klassifizierung bösartiger Melanome
CN116848246A (zh) * 2021-02-10 2023-10-03 上海奕拓医药科技有限责任公司 调节src-1凝聚体的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447841A (en) 1986-01-16 1995-09-05 The Regents Of The Univ. Of California Methods for chromosome-specific staining
US5028525A (en) 1986-11-24 1991-07-02 Regents Of The University Of California Method of preparing and applying single stranded DNA probes to double stranded target DNAs in situ
EP0552202B2 (de) 1990-09-21 2005-09-28 The Salk Institute For Biological Studies Durch protoonkogenischen Proteinkomplex AP-1 kontrollierte Verfahren
CA2133580A1 (en) 1992-05-06 1993-11-11 David M. Goldenberg Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
US5472842A (en) 1993-10-06 1995-12-05 The Regents Of The University Of California Detection of amplified or deleted chromosomal regions
US5506102A (en) 1993-10-28 1996-04-09 Ligand Pharmaceuticals Incorporated Methods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcription
US5750336A (en) * 1994-02-10 1998-05-12 The Salk Institute For Biological Studies Assays for the identification of compounds which inhibit activation of cAMP and mitogen responsive genes
JP3517988B2 (ja) * 1994-09-21 2004-04-12 小野薬品工業株式会社 ヒトマッカード−ジョセフ病関連蛋白質、その蛋白質をコードするｃＤＮＡおよび遺伝子、そのＤＮＡまたは遺伝子を含むベクター、その発現ベクターで形質転換された宿主細胞、マッカード−ジョセフ病の診断方法および治療剤
WO1997010337A1 (en) * 1995-09-15 1997-03-20 Baylor College Of Medicine Steroid receptor coactivator compositions and methods of use
WO1997035195A1 (en) 1996-03-19 1997-09-25 The Salk Institute For Biological Studies In vitro methods for identifying modulators of members of the steroid/thyroid superfamily of receptors
WO1998003652A2 (en) * 1996-07-23 1998-01-29 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services P300/cbp-associated transcriptional co-factor p/caf and uses thereof
US6812336B1 (en) * 1997-06-12 2004-11-02 The Regents Of The University Of California Transcription factor coactivator protein, p/CIP

Also Published As

Publication number Publication date
US20090023645A1 (en) 2009-01-22
US6562589B1 (en) 2003-05-13
EP0988317B1 (de) 2008-04-23
CA2295332C (en) 2011-02-15
WO1998057982A2 (en) 1998-12-23
JP2002510208A (ja) 2002-04-02
CA2295332A1 (en) 1998-12-23
EP0988317A2 (de) 2000-03-29
US20030153047A1 (en) 2003-08-14
US7232890B2 (en) 2007-06-19
DE69839395D1 (de) 2008-06-05
AU732149B2 (en) 2001-04-12
AU8150698A (en) 1999-01-04
WO1998057982A3 (en) 1999-03-18

Similar Documents

Publication Publication Date Title
ATE393163T1 (de) Aib1, ein steroidrezeptor co-aktivator
Thompson Molecular cloning and expression of carcinoembryonic antigen gene family members
EP0932699A4 (de) Methode und reagenziensätze zum gewinnen und testen von brustflüssigkeitsproben um brustkrankheiten, einschliesslich krebs, nachzuweisen
EP0734264A4 (de) Verbindungen die spezifisch an kolorektale krebszellen binden und verfahren fuerihre herstellung
PT1015608E (pt) Metodos de ensaio de actividade de receptor e construcoes uteis nesses metodos
HUP0102744A2 (hu) Eljárás rákbetegségek korai diagnosztizálására
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
YU83600A (sh) Adenozin a3 receptorski modulatori
CA2284817A1 (en) Method for determining the presence of mutated brca protein
DE68901632D1 (de) Reaktionsgefaess zur durchfuehrung von aufeinanderfolgenden analytischen testen.
ATE433106T1 (de) Bestimmungsmethode fur liganden der nuklearen rezeptoren
DE68919296D1 (de) Zweiteiliger, keramischer Soller-Schlitzkollimator für die Röntgenkollimation.
IL127490A0 (en) On-the-fly accuracy enhancement for civil gps receivers
AU588542B2 (en) Immunoassay for breast cancer employing monoclonal antibodies
DE59911879D1 (de) Verwendung von biogenen estrogensulfamaten zur hormonsubstitutionstherapie
ATE58437T1 (de) Nuklearbindungstest fuer steroidrezeptorsfunktion in krebsartigen zellen.
GB2327497B (en) Diagnostic assay for cancer
WO1999045143A3 (en) A fluorescence polarization screening method
ATE359291T1 (de) Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
DE69033128D1 (de) Für leberzellkarzinom spezifisches onkogen
EP0373192A4 (en) Diagnostic genes for toxoplasmosis
ATE198512T1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
DE60043942D1 (de) Fluoreszierende cobalamine und deren verwendung
Cappelletti et al. Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors
IL130164A0 (en) Mammalian chemokines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties